表紙:自動・閉鎖型細胞調整システムの世界市場:ワークフロー別(分離、拡張)、タイプ別(非幹細胞、幹細胞)、規模別の市場規模、シェアおよび動向分析、セグメント別予測(2021年~2028年)
市場調査レポート
商品コード
1036653

自動・閉鎖型細胞調整システムの世界市場:ワークフロー別(分離、拡張)、タイプ別(非幹細胞、幹細胞)、規模別の市場規模、シェアおよび動向分析、セグメント別予測(2021年~2028年)

Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation, Expansion), By Type (Non-stem Cell, Stem Cell), By Scale, And Segment Forecasts, 2021 - 2028

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 136 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
自動・閉鎖型細胞調整システムの世界市場:ワークフロー別(分離、拡張)、タイプ別(非幹細胞、幹細胞)、規模別の市場規模、シェアおよび動向分析、セグメント別予測(2021年~2028年)
出版日: 2021年11月12日
発行: Grand View Research, Inc.
ページ情報: 英文 136 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の自動・閉鎖型細胞調整システムの市場規模は、予測期間中に21.7%のCAGRで拡大し、2028年までに29億4,000万米ドルに達すると予想されています。

市場関係者は、細胞治療製品の開発プロセスを加速させるための戦略として、自動化プロセスシステムの導入に多額の投資を行っており、これが市場成長の原動力となっています。

GMP製造施設の拡大は、商業活動における自動化プロセスの導入をさらに後押ししています。また、単回使用の使い捨てチューブセットやバッグは応用範囲が広いため、治療研究開発の自動化が促進されます。さらに、主要企業は製造ラボに自動化技術を効果的に導入するための戦略を立てており、これが収益の拡大につながっています。

当レポートでは、世界の自動・閉鎖型細胞調整システム市場について調査分析し、市場および業界展望、セグメント別・地域別市場の展望の他、競合情勢について、体系的な情報を提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場セグメンテーション

第4章 業界の見通し

  • 親市場の系統
  • 補助的な市場系統
  • 市場力学
    • 市場の成長要因分析
    • 市場の抑制要因分析
    • 市場の機会分析
    • 市場の課題分析
  • SWOT分析;要因別(政治的および法的、経済的および技術的)
  • ポーターのファイブフォース分析
  • 主要な取引と戦略的提携の分析
    • 合併・買収
    • 技術協力とパートナーシップ
    • 製品の承認と発売
  • Covid-19の影響分析
    • 課題分析
    • 市場機会分析
    • 主要動向と活動

第5章 競合分析

  • 企業のマッピング
  • 潜在的なエンドユーザーのリスト
  • 新興企業のリスト
  • 市場の差別化要因
  • 競合のダッシュボード分析
  • 地域ネットワークマップ

第6章 ワークフロー別市場分析

  • 自動・閉鎖型細胞調整システム市場:ワークフロー別市場の動向分析
  • 分離
  • 拡張
  • アフェレーシス
  • 充填・仕上げ
  • 凍結保存
  • その他

第7章 タイプ別市場分析

  • 自動・閉鎖型細胞調整システム市場:タイプ別市場の動向分析
  • 幹細胞治療
  • 非幹細胞治療

第8章 規模別市場分析

  • 自動・閉鎖型細胞調整システム市場:規模別市場の動向分析
  • プレコマーシャル/R&D規模製造
  • 商業規模の製造

第9章 地域別市場分析

  • 自動・閉鎖型細胞調整システム市場:地域別市場の動向分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 企業プロファイル

  • 戦略の枠組み
  • 市場参入の分類
  • 企業プロファイル
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of automated and closed cell therapy processing systems manufacturers
  • Table 3 List of potential end-users
  • Table 4 List of emerging players
  • Table 5 List of market differentiators
  • Table 6 Competitive dashboard analysis
  • Table 7 Regional network map
  • Table 8 North America automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 9 North America automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 10 North America automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 11 U.S. automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 12 U.S. automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 13 U.S. automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 14 Canada automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 15 Canada automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 16 Canada automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 17 Europe automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 18 Europe automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 19 Europe automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 20 Germany automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 21 Germany automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 22 Germany automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 23 U.K. automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 24 U.K. automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 25 U.K. automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 26 Italy automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 27 Italy automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 28 Italy automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 29 Spain automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 30 Spain automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 31 Spain automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 32 France automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 33 France automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 34 France America automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 35 Asia Pacific automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 36 Asia Pacific automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 37 Asia Pacific automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 38 China automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 39 China automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 40 China automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 41 Japan automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 42 Japan automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 43 Japan automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 44 India automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 45 India automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 46 India automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 47 South Korea automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 48 South Korea automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 49 South Korea automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 50 Australia automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 51 Australia automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 52 Australia automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 53 Latin America automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 54 Latin America automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 55 Latin America automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 56 Brazil automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 57 Brazil automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 58 Brazil automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 59 Mexico automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 60 Mexico automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 61 Mexico automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 62 MEA automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 63 MEA automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 64 MEA automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 65 South Africa automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 66 South Africa automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 67 South Africa automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 68 Saudi Arabia automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 69 Saudi Arabia automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 70 Saudi Arabia automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 71 UAE automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 72 UAE automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 73 UAE automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Classification of companies
  • Fig. 9 Automated and closed cell therapy processing systems market snapshot, 2020 (USD Million)
  • Fig. 10 Automated and Closed Cell Therapy Processing System Market segmentation
  • Fig. 11 Market driver impact
  • Fig. 12 Market restraint impact
  • Fig. 13 Automated and closed cell therapy processing systems market SWOT analysis
  • Fig. 14 Automated and closed cell therapy processing systems market Porter's five forces analysis
  • Fig. 15 Automated and closed cell therapy processing systems market : Workflow outlook and key takeaways
  • Fig. 16 Automated and closed cell therapy processing systems market : Workflow movement analysis
  • Fig. 17 Separation market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 18 Expansion market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 19 Apheres is market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 20 Fill-Finish market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 21 Cryopreservation market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 22 Others market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 23 Automated and closed cell therapy processing systems market : Type outlook and key takeaways
  • Fig. 24 Automated and closed cell therapy processing systems market : Type movement analysis
  • Fig. 25 Stem cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 26 Non-stem cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 27 Automated and closed cell therapy processing systems market : Scaleoutlook and key takeaways
  • Fig. 28 Automated and closed cell therapy processing systems market : Scale movement analysis
  • Fig. 29 Pre-commercial/ R&D scale manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 30 Commercial scale manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 31 Automated and closed cell therapy processing systems market : Regional outlook and key takeaways
  • Fig. 32 Automated and closed cell therapy processing systems market : Regional movement analysis
  • Fig. 33 North America automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 34 U.S. automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 35 Canada cell and gene therapy manufacturing) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 36 Europe automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 37 Germany automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 38 U.K. automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 39 France automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 40 Italy automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 41 Spain automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 42 Asia Pacific automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 43 Japan automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 44 China automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 45 India automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 46 South Korea automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 47 Australia automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 48 Latin America automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 49 Brazil automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 50 Mexico automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 51 Middle East & Africa automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 52 South Africa automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 53 Saudi Arabia automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 54 UAE automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 55 Strategy framework
  • Fig. 56 Market participation categorization
目次
Product Code: GVR-4-68038-382-9

Automated And Closed Cell Therapy Processing Systems Market Growth & Trends:

The global automated and closed cell therapy processing systems market is expected to reach USD 2.94 billion by 2028, registering a CAGR of 21.7% over the forecast period, according to a new report by Grand View Research, Inc. Market players are making significant investments to introduce an automated process system as a viable strategy to accelerate their cell therapy product development process, thereby driving market growth.

The expansion of GMP manufacturing facilities further supports the implementation of automated processes for commercial operations. In addition, the wide application scope of single-use disposable tubing sets and bags also facilitates automated processing of therapy R&D. Moreover, key entities are undertaking strategies for effective implementation of automation technology in manufacturing labs resulting in lucrative revenue growth.

The rapid growth in the cases of COVID-19 is anticipated to play a vital role in the market growth. The pandemic has led to an increased focus on automation technologies. Moreover, the companies emphasized raising funds with an aim to develop advanced therapies and regenerative medicines to fight against COVID-19. Industry players are also concentrating on the development of new therapies, such as stem cell therapy, natural killer cell therapy, exosomes, and others.

Automated And Closed Cell Therapy Processing Systems Market Report Highlights:

  • The cell expansion workflow segment accounted for the maximum revenue share of the global market in 2020. An increasing focus on achieving high output yield has resulted in the high revenue share of the segment
  • The cell separation workflow segment is estimated to register the fastest CAGR during the forecast period due to an increasing number of stem cell therapy R&D programs
  • Automated apheresis and cryopreservation workflow are also expected to register considerable growth rates over the forecast period due to the growing emphasis on preservation and sorting for cell therapies
  • The non-stem cellular therapies segment dominated the market in 2020 and will expand further at a steady CAGR over the forecast period. The success of CAR T therapies is one of the major driving forces of this segment
  • The pre-commercial/R&D scale segment captured the maximum revenue share in 2020 due to the increased number of research and innovation activities for new drug & therapy developments
  • North America emerged as the highest revenue-generating region in 2020 owing to the presence of a large number of approved therapies in the region influencing the market players to invest in more R&D programs
  • Companies are undertaking strategic initiatives, such as partnerships and collaborations, to gain higher market shares. For instance, in January 2021, Fresenius Kabiformed a joint venture with Bio-Techne to launch ScaleReady, to develop a scalable and versatile therapy manufacturing platform

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 Gvr's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
    • 1.4.5 Details Of Primary Research
  • 1.5 Information or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
      • 1.7.1.1. Approach 1: Commodity Flow Approach
      • 1.7.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.8 Market: CAGR Calculation
  • 1.9 List of Secondary Sources
  • 1.10 Objectives
    • 1.10.1 Objective 1:
    • 1.10.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Competition Milieu
  • 2.2 Segment Outlook
  • 2.3 Market Summary, 2020 (USD Million)

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation

Chapter 4 Industry Outlook

  • 4.1 Parent Market Lineage
  • 4.2 Ancillary Market Lineage
  • 4.3 Market Dynamics
    • 4.3.1 Market driver analysis
      • 4.3.1.1 Rising Emphasis On Regenerative Medicines And Cell Therapies
      • 4.3.1.2 Operational Superiority Of Automated Systems Over Manual Processing
      • 4.3.1.3 Extensively Increasing Technological Advancements
    • 4.3.2 Market Restraint Analysis
      • 4.3.2.1 Biological Variations Associated With Different Therapies
    • 4.3.3 Market opportunity analysis
      • 4.3.3.1 Growing Fund-Raising Activities By Companies For New Technology Development
      • 4.3.3.2 Research Activitis And Product Innovations
    • 4.3.4 Market Challenge Analysis
      • 4.3.4.1 Complicated Process Of Automation
  • 4.4 SWOT Analysis; by Factor (Political & Legal, Economic and Technological)
  • 4.5 Porter's Five Forces Analysis
  • 4.6 Major Deals and Strategic Alliances Analysis
    • 4.6.1 Mergers And Acquisitions
    • 4.6.2 Technological Collaborations And Partnerships
    • 4.6.3 Product Approvals And Launches
  • 4.7 Covid-19 Impact Analysis
    • 4.7.1 Challenge Analysis
    • 4.7.2 Opportunity Analysis
    • 4.7.3 Key Developments And Activities

Chapter 5 Competitive Analysis

  • 5.1 Company Mapping
  • 5.2 List of Potential End Users
  • 5.3 List of Emerging Players
  • 5.4 Market Differentiators
  • 5.5 Competitive Dashboard Analysis
  • 5.6 Regional Network Map

Chapter 6 Workflow Business Analysis

  • 6.1 Automated and Closed Cell Therapy Processing Systems Market: Workflow Movement Analysis
  • 6.2 Separation
    • 6.2.1 Separation Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.3 Expansion
    • 6.3.1 Expansion market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.4 Apheresis
    • 6.4.1 Apheresis market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.5 Fill-Finish
    • 6.5.1 Fill-Finish Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.6 Cryopreservation
    • 6.6.1 Cryopreservation market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.7 Others
    • 6.7.1 Others Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 7 Type Business Analysis

  • 7.1 Automated and Closed Cell Therapy Processing Systems Market: Type Movement Analysis
  • 7.2 Stem Cell Therapy
    • 7.2.1 Stem Cell Therapy Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 7.3 Non-Stem Cell Therapy
    • 7.3.1 Non-Stem Cell Therapy Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 8 Scale Business Analysis

  • 8.1 Automated and Closed Cell Therapy Processing Systems Market: Scale Movement Analysis
  • 8.2 Pre-Commercial/R&D Scale Manufacturing
    • 8.2.1 Pre-Commercial/R&D Scale Manufacturing Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 8.3 Commercial Scale Manufacturing
    • 8.3.1 Commercial Scale Manufacturing Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 9 Regional Business Analysis

  • 9.1 Automated and Closed Cell Therapy Processing Systems Market: Regional Movement Analysis
  • 9.2 North America
    • 9.2.1 North America Automated And Closed Cell Therapy Processing Sysytems Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.2.2 U.S.
      • 9.2.2.1 U.S. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.2.2.2 U.S. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.2.2.3 U.S. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.2.3 Canada
      • 9.2.3.1 Canada Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.2.3.2 Canada Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.2.3.3 Canada Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.3.2 Germany
      • 9.3.2.1 Germany Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.3.2.2 Germany Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.3.2.3 Germany Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.3.3 U.K.
      • 9.3.3.1 U.K. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.3.3.2 U.K. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.3.3.3 U.K. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.3.4 France
      • 9.3.4.1 France Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.3.4.2 France Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.3.4.3 France Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.3.5 Italy
      • 9.3.5.1 Italy Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.3.5.2 Italy Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.3.5.3 Italy Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.3.6 Spain
      • 9.3.6.1 Spain Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.3.6.2 Spain Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.3.6.3 Spain Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific Automated And Closed Cell Therapy Processing Systems Market estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.4.2 Japan
      • 9.4.2.1 Japan Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.4.2.2 Japan Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.4.2.3 Japan Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.4.3 China
      • 9.4.3.1 China Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.4.3.2 China Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.4.3.3 China Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.4.4 India
      • 9.4.4.1 India Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.4.4.2 India Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.4.4.3 India Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.4.5 South Korea
      • 9.4.5.1 South Korea Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.4.5.2 South Korea Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.4.5.3 South Korea Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.4.6 Australia
      • 9.4.6.1 Australia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.4.6.2 Australia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.4.6.3 Australia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America automated And Closed Cell Therapy Processing Systems Market estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.5.2 Brazil
      • 9.5.2.1 Brazil Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.5.2.2 Brazil Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.5.2.3 Brazil Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.5.3 Mexico
      • 9.5.3.1 Mexico Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.5.3.2 Mexico Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.5.3.3 Mexico Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
  • 9.6 Middle East & Africa
    • 9.6.1 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.6.2 South Africa
      • 9.6.2.1 South Africa Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.6.2.2 South Africa Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.6.2.3 South Africa Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.6.3 Saudi Arabia
      • 9.6.3.1 Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.6.3.2 Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.6.3.3 Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.6.4 UAE
      • 9.6.4.1 UAE Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.6.4.2 UAE Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.6.4.3 UAE Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)

Chapter 10 Company Profiles

  • 10.1 Strategy Framework
  • 10.2 Market Participation Categorization
  • 10.3 Company Profiles
    • 10.3.1 MILTENYI BIOTEC
      • 10.3.1.1 Company Overview
      • 10.3.1.2 Product Benchmarking
      • 10.3.1.3 Strategic Initiatives
    • 10.3.2 LONZA
      • 10.3.2.1 Company Overview
      • 10.3.2.2 Financial Performance
      • 10.3.2.3 Product Benchmarking
      • 10.3.2.4 Strategic Initiatives
    • 10.3.3 FRESENIUS KABI
      • 10.3.3.1 Company Overview
      • 10.3.3.2 Financial Performance
      • 10.3.3.3 Product Benchmarking
      • 10.3.3.4 Startegic Initiatives
    • 10.3.4 CYTIVA (DANAHER CORPORATION)
      • 10.3.4.1 Company Overview
      • 10.3.4.2 Financial Performance
      • 10.3.4.3 Product Benchmarking
      • 10.3.4.4 Startegic Initiatives
    • 10.3.5 BIOSPHERIX, LTD.
      • 10.3.5.1 Company Overview
      • 10.3.5.2 Product Benchmarking
      • 10.3.5.3 Startegic Initiatives
    • 10.3.6 TERUMO CORPORATION
      • 10.3.6.1 Company Overview
      • 10.3.6.2 Financial Performance
      • 10.3.6.3 Product Benchmarking
      • 10.3.6.4 Startegic Initiatives
    • 10.3.7 SARTORIUS AG
      • 10.3.7.1 Company Overview
      • 10.3.7.2 Financial Performance
      • 10.3.7.3 Product Benchmarking
      • 10.3.7.4 Startegic Initiatives
    • 10.3.8 THERMOGENESIS HOLDINGS, INC.
      • 10.3.8.1 Company Overview
      • 10.3.8.2 Financial Performance
      • 10.3.8.3 Product Benchmarking
      • 10.3.8.4 Startegic Initiatives
    • 10.3.9 CELLARES INC.
      • 10.3.9.1 Company Overview
      • 10.3.9.2 Product Benchmarking
      • 10.3.9.3 Startegic Initiatives
    • 10.3.10 THERMO FISHER SCIENTIFIC, INC.
      • 10.3.10.1 Company Overview
      • 10.3.10.2 Financial Performance
      • 10.3.10.3 Product Benchmarking
      • 10.3.10.4 Startegic Initiatives